OneSource Specialty Pharma Limited (NSE:ONESOURCE)

Market Cap	204.71B
Revenue (ttm)	14.80B
Net Income (ttm)	-126.10M
Shares Out	114.53M
EPS (ttm)	-1.19
PE Ratio	n/a
Forward PE	43.09
Dividend	n/a
Ex-Dividend Date	n/a

Volume	138,783
Average Volume	161,273
Open	1,823.00
Previous Close	1,840.40
Day's Range	1,779.90 - 1,823.00
52-Week Range	1,209.95 - 2,248.00
Beta	n/a
RSI	42.65
Earnings Date	Nov 4, 2025

About NSE:ONESOURCE

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 1,412
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ONESOURCE

Financial Performance

In 2024, NSE:ONESOURCE's revenue was 14.45 billion, an increase of 740.43% compared to the previous year's 1.72 billion. Losses were -179.71 million, -95.41% less than in 2023.